This article is more than 5 years old. Information may no longer be current.

FDA clears Nephros EndoPur filter

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

The U.S. Food and Drug Administration has granted 510(k) clearance to Nephros Inc. for its EndoPur Endotoxin 10” Filter.

The filter fits into existing filter cartridge housings of the reverse osmosis water systems that provide dialysis clinics with high volumes of ultrapure water. The EndoPur offers dialysis clinics an endotoxin barrier with the smallest pore size on the market, according to Nephros.

“With the FDA clearance of the EndoPur, we have achieved a significant milestone in the expansion of our dialysis water filter portfolio,” said Daron Evans, president and CEO of Nephros.

Nephros said they expect to begin selling the EndoPur to customers in the second quarter of 2017.